Ads
related to: medication for sundowners in adults with dementia pdfmcpress.mayoclinic.org has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
But in people with dementia—which is an umbrella term for mental decline and can be related to a number of diseases such as Alzheimer's—there’s a phenomenon known as “sundowning,” where ...
Sundowning, or sundown syndrome, [1] is a neurological phenomenon wherein people with delirium or some form of dementia experience increased confusion and restlessness beginning in the late afternoon and early evening.
Wandering occurs when a person with dementia roams around and becomes lost or confused about their location. It is a common behavior that can cause great risk for the person, and is often the major priority (and concern) for caregivers. It is estimated to be the most common form of disruption from people with dementia within institutions. [1]
They concluded that, if the MATCH-D were successfully implemented that the relative hazards of medicines use for people with dementia would need to be re-evaluated. The National Health and Medical Research Council (NHMRC) are currently funding a randomised controlled trial implementing the MATCH-D using pharmacists embedded in general practice.
Researchers from the Karolinska Institutet have found that Alzheimer’s disease medications called cholinesterase inhibitors may help slow down cognitive decline in people with dementia with Lewy ...
Simulated presence therapy (SPT) is an emotion-oriented non-pharmacological intervention for people with dementia developed by P. Woods and J. Ashley in 1995. SPT was created as part of a study conducted in a nursing home where 17 individuals with the disease listened to a recording of a caregiver over a stereo. [1]
The CDC said 1.7% of adults ages 65 to 74 reported a dementia diagnosis, a rate that increased with age. For those ages 75 to 84, the reported dementia rate was 5.7%
Rivastigmine, sold under the brand name Exelon among others, is an acetylcholinesterase inhibitor used for the treatment of dementia associated with Alzheimer's disease and with Parkinson's disease. [ 4 ] [ 6 ] [ 7 ] Rivastigmine can be administered orally or via a transdermal patch ; the latter form reduces the prevalence of side effects, [ 8 ...
Ads
related to: medication for sundowners in adults with dementia pdfmcpress.mayoclinic.org has been visited by 100K+ users in the past month